Femnu 2.5mg Tablet
Marketer
Genesis Biotech Inc
Salt Composition
Letrozole (2.5mg)
Overview Femnu 2.5mg Tablet
Postmenopausal women with breast cancer may find relief with EstroFem 2.5mg tablets. This medication can be administered independently or in conjunction with other therapies like surgery or radiotherapy. It's also indicated for advanced breast cancer to inhibit metastasis. EstroFem 2.5mg tablets may be taken with or without food, following your physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal, determined by your doctor to manage your symptoms effectively. Continuous use is crucial as directed. Common side effects include vasomotor flushes, tiredness, diaphoresis, and elevated cholesterol. Report any concerning or persistent side effects to your doctor immediately; management strategies may be available. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, or history of osteoporosis. Full disclosure of all current medications is essential, as interactions may compromise efficacy or alter the drug's action. Disclose any pregnancy or breastfeeding status to your doctor. Pre- and ongoing treatment may involve blood tests to monitor vitamin D levels and bone density.
Uses of Femnu 2.5mg Tablet
Managing breast cancer
Major Benefits of Femnu 2.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Femnu 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Femnu 2.5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Femnu 2.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Femnu tablet whole; do not chew, crush, or divide it. While you can take it with or without food, consistency is key—maintain a regular daily schedule.
How Femnu 2.5mg Tablet works:
Aromatase inhibitor Femnu 2.5mg Tablets reduce estrogen, a key female hormone, in the body. This reduction can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Femnu 2.5mg Tablet and alcohol.
PregnancyUNSAFE
Taking Femnu 2.5mg Tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in animals and pregnant humans indicates significant potential harm to the fetus.
Breast feedingUNSAFE
Lactation is contraindicated with Femnu 2.5mg Tablets due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Taking a 2.5mg Femnu tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if such effects are experienced.
KidneySAFE IF PRESCRIBED
Femnu 2.5mg tablets are considered safe for patients with kidney impairment; no dosage alteration is typically necessary. Limited data exists regarding its use in individuals with end-stage renal disease. Physician consultation is advised.
LiverCAUTION
Caution is advised when prescribing Femnu 2.5mg Tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Femnu 2.5mg Tablet :
Should you forget to take your Femnu 2.5mg Tablet, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Femnu 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently